Optimal treatments in cost-effectiveness analysis in the presence of covariates: Improving patient subgroup definition
In the presence of covariates, the cost-effectiveness analysis of medical treatments shows that the optimal treatment varies across the patient population subgroups, and hence to accurately define the subgroups is a crucial step in the analysis. A patient subgroup definition using only influential covariates within the potential set of patients covariates established by the expert has recently been proposed, and the influential covariates were chosen from the univariate distributions of the effectiveness and the cost, conditional on the effectiveness. In this paper, we argue that the Bayesian variable selection procedure should be developed using the bivariate distribution of the cost and the effectiveness, which is not the usual practice. This new approach, provides results with wider applicability and more understandable without a significative increase in the complexity of the procedure. For real and simulated data sets, optimal treatments for subgroups are found, and compared with that from previous methods.
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Andrea Manca & Mark J. Sculpher & Ron Goeree, 2010. "The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions: A Critical Appraisal of Recent Methodological Developments," PharmacoEconomics, Springer Healthcare | Adis, vol. 28(12), pages 1079-1096.
- Moreno, Elías & Girón, F.J. & Vázquez-Polo, F.J. & NegrIÂ´n, M.A., 2010. "Optimal healthcare decisions: Comparing medical treatments on a cost-effectiveness basis," European Journal of Operational Research, Elsevier, vol. 204(1), pages 180-187, July.
- Casella, George & Moreno, Elias, 2006. "Objective Bayesian Variable Selection," Journal of the American Statistical Association, American Statistical Association, vol. 101, pages 157-167, March.
- Casella, George & Moreno, ElÃas, 2009. "Assessing Robustness of Intrinsic Tests of Independence in Two-Way Contingency Tables," Journal of the American Statistical Association, American Statistical Association, vol. 104(487), pages 1261-1271.
- Mark Sculpher, 2008. "Subgroups and Heterogeneity in Cost-Effectiveness Analysis," PharmacoEconomics, Springer Healthcare | Adis, vol. 26(9), pages 799-806.
- Aaron A. Stinnett & John Mullahy, 1998. "Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis," NBER Technical Working Papers 0227, National Bureau of Economic Research, Inc.
- Liang, Feng & Paulo, Rui & Molina, German & Clyde, Merlise A. & Berger, Jim O., 2008. "Mixtures of g Priors for Bayesian Variable Selection," Journal of the American Statistical Association, American Statistical Association, vol. 103, pages 410-423, March.
- Elías Moreno & F. Girón, 2008. "Comparison of Bayesian objective procedures for variable selection in linear regression," TEST: An Official Journal of the Spanish Society of Statistics and Operations Research, Springer, vol. 17(3), pages 472-490, November.
- Brailsford, Sally & Harper, Paul, 2008. "OR in Health," European Journal of Operational Research, Elsevier, vol. 185(3), pages 901-904, March.
- Francisco-José Polo & Miguel Negrín & Xavier Badía & Montse Roset, 2005. "Bayesian regression models for cost-effectiveness analysis," The European Journal of Health Economics, Springer, vol. 6(1), pages 45-52, March.
- Andrew R. Willan & Andrew H. Briggs & Jeffrey S. Hoch, 2004. "Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data," Health Economics, John Wiley & Sons, Ltd., vol. 13(5), pages 461-475.
- Maiwenn J. Al & Ben A. Van Hout, 2000. "A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty," Health Economics, John Wiley & Sons, Ltd., vol. 9(7), pages 599-609.
- Mark Sculpher & Amiram Gafni, 2001. "Recognizing diversity in public preferences: The use of preference sub-groups in cost-effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 10(4), pages 317-324.
- F. J. Vázquez-Polo & M. A. Negr�n Hernández & B. González López-Valcárcel, 2005. "Using covariates to reduce uncertainty in the economic evaluation of clinical trial data," Health Economics, John Wiley & Sons, Ltd., vol. 14(6), pages 545-557.
- Elías Moreno & F. Girón, 2008. "Comparison of Bayesian objective procedures for variable selection in linear regression," TEST: An Official Journal of the Spanish Society of Statistics and Operations Research, Springer, vol. 17(3), pages 491-492, November.
- Richard M. Nixon & Simon G. Thompson, 2005. "Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations," Health Economics, John Wiley & Sons, Ltd., vol. 14(12), pages 1217-1229.
- Gerald Richardson & Andrea Manca, 2004. "Calculation of quality adjusted life years in the published literature: a review of methodology and transparency," Health Economics, John Wiley & Sons, Ltd., vol. 13(12), pages 1203-1210.
- Claxton, Karl, 1999. "The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies," Journal of Health Economics, Elsevier, vol. 18(3), pages 341-364, June.
- Moreno, Elías & Girón, F.J. & Vázquez-Polo, F.J. & Negrín, M.A., 2012. "Optimal healthcare decisions: The importance of the covariates in cost–effectiveness analysis," European Journal of Operational Research, Elsevier, vol. 218(2), pages 512-522.
When requesting a correction, please mention this item's handle: RePEc:eee:ejores:v:226:y:2013:i:1:p:173-182. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Zhang, Lei)
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.